The study aims to enhance U.S. public health preparedness through the Walgreens community pharmacy network, improving access and diversity in clinical trials via a $25 million award.
Topiramate extended-release capsules are indicated for the treatment of partial-onset or primary generalized tonic-clonic seizures in certain patients.